Premature ovarian failure (POF) is an heterogeneous syndrome. Women can pre
sent with primary amenorrhea or secondary amenorrhea occurring before the a
ge of 40. Nearly 2 % of the female population is affected this disorder, It
s pathophysiology still remains obscure. Different hypotheses can be propos
ed: a reduction in the number of primordial follicles, an accelerated or in
creased atresia, a defect in the genes involved in follicular recruitement
and finally a blockade in follicular growth. Up to now, few causes have bee
n identified: toxic, autoimmune and genetic. Chemotherapy and radiotherapy
lead either to a reversible or to a permanent gonadal dysfunction, accordin
g to the type of drug, the doses and the patient's age at the time of treat
ment. Polyendocrinopathies and animal models seem to involve autoimmune dis
orders as a cause of premature ovarian failure. The mechanisms, through whi
ch mutations in the AIRE gene responsable for the APECED syndrome can leed
to ovarian insufficiency, are still unknown. It is likely that studies on t
he function of the AIRE protein, a transcription factor, might improve our
knowledge. Among genetic causes, X monosomy as in Turner syndrome or X dele
tions and translocations are known to be responsible for POF. The genes or
the X chromosome involved in ovarian function are still unknown. Furthermor
e, autosomal abnormalities have been identified as mutations of LH and FSH
genes, their receptor genes, chromosome 3q, Ataxia-telangiectasia genes, th
e AIRE gene. Meanwhile, the cause of POF remains idiopathic in most cases.
In the future, a better knowledge of the cellular and biochemical component
s implied in folliculogenesis and apoptosis should elucidate the mechanisms
of POF.